NEUROPEDIATRICS, vol.54, no.4, pp.225-238, 2022 (SCI-Expanded)
Background Although the underlying genetic causes of intellectual disability (ID) continue to be rapidly identified, the biological pathways and processes that could be targets for a potential molecular therapy are not yet known. This study aimed to identify ID-related shared pathways and processes utilizing enrichment analyses.